You have 9 free searches left this month | for more free features.

Imetelstat

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • Imetelstat
  • (no location specified)
Jun 30, 2023

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Imetelstat
  • Adelaide, Australia
  • +11 more
Oct 13, 2022

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
  • Primary Myelofibrosis
  • +2 more
  • Imetelstat
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Neuroblastoma Trial in Montreal (Imetelstat)

Withdrawn
  • Neuroblastoma
  • Imetelstat
  • Montreal, Quebec, Canada
    CHU Sainte-Justine
Sep 17, 2020

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • Imetelstat
  • Best Available Therapy (BAT)
  • La Jolla, California
  • +165 more
Aug 19, 2022

Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer Trial (Imetelstat Sodium,

Withdrawn
  • Hepatoblastoma
  • +7 more
  • Imetelstat Sodium
  • Laboratory Biomarker Analysis
  • (no location specified)
Aug 3, 2018

Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

Terminated
  • Anaplastic Astrocytoma
  • +8 more
  • imetelstat sodium
  • Los Angeles, California
  • +10 more
Jun 20, 2018

Multiple Myeloma Trial in Baltimore (Imetelstat (7.5 mg/kg), lenalidomide standard of care, Imetelstat (9.4 mg/kg))

Completed
  • Multiple Myeloma
  • Imetelstat (7.5 mg/kg)
  • +2 more
  • Baltimore, Maryland
  • +1 more
Apr 13, 2016

Essential Thrombocythemia, Polycythemia Vera Trial in Germany, Switzerland, United States (Imetelstat)

Completed
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Imetelstat
  • Duarte, California
  • +11 more
Dec 22, 2015

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (motesanib diphosphate)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • motesanib diphosphate
  • Burbank, California
  • +18 more
Dec 12, 2017

NSCLC Trial in Canada, Germany, United States (imetelstat, Bevacizumab)

Completed
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Dec 22, 2015

Locally Recurrent or Metastatic Breast Cancer Trial in Canada, United States (Imetelstat sodium, Bevacizumab, Paclitaxel)

Completed
  • Locally Recurrent or Metastatic Breast Cancer
  • Imetelstat sodium
  • +2 more
  • Huntsville, Alabama
  • +54 more
Dec 22, 2015

Solid Tumor Malignancies Trial in Chicago, Detroit (Imetelstat Sodium (GRN163L))

Completed
  • Solid Tumor Malignancies
  • Imetelstat Sodium (GRN163L)
  • Chicago, Illinois
  • +1 more
Dec 22, 2015

Multiple Myeloma Trial in Detroit, New York City, Seattle (Imetelstat Sodium (GRN163L))

Completed
  • Multiple Myeloma
  • Imetelstat Sodium (GRN163L)
  • Detroit, Michigan
  • +2 more
Dec 22, 2015

Advanced Solid Tumors Trial (Sorafenib, AMG 706, AMG 386)

Completed
  • Advanced Solid Tumors
  • (no location specified)
Feb 7, 2017

Multiple Myeloma Trial in Baltimore, Boston, Buffalo (Imetelstat Sodium (GRN163L))

Completed
  • Multiple Myeloma
  • Imetelstat Sodium (GRN163L)
  • Baltimore, Maryland
  • +2 more
Dec 22, 2015

Lung Cancer Trial in United States (Imetelstat Sodium (GRN163L))

Completed
  • Lung Cancer
  • Imetelstat Sodium (GRN163L)
  • Baltimore, Maryland
  • +3 more
Dec 22, 2015

Breast Tumors Trial in Indianapolis (GRN163L in combination with trastuzumab)

Completed
  • Breast Neoplasms
  • GRN163L in combination with trastuzumab
  • Indianapolis, Indiana
    Indiana University Simon Cancer Center
Oct 26, 2015

Breast Cancer, Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Philadelphia (Ixabepilone, Capecitabine, Motesanib)

Withdrawn
  • Breast Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Chronic Lymphoproliferative Diseases Trial in United States (GRN163L)

Completed
  • Chronic Lymphoproliferative Diseases
  • Denver, Colorado
  • +7 more
Dec 22, 2015

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome Trial in United States (AMG 706, octreotide)

Completed
  • Gastrointestinal Carcinoid Tumor
  • +2 more
  • Berwyn, Illinois
  • +111 more
Jul 12, 2016

Solid Tumors Trial (AMG 706)

Terminated
  • Solid Tumors
  • AMG 706
  • (no location specified)
Sep 24, 2015

Breast Tumors, Breast Tumors, Breast Cancer Trial (AMG 706 , Bevacizumab, AMG 706)

Terminated
  • Breast Neoplasms
  • +3 more
  • AMG 706 placebo
  • +3 more
  • (no location specified)
Sep 24, 2015